RE-BVS – Piemonte Repository

Sfoglia per AUTORE
LIBENER R
Collezione AOU San Luigi di Orbassano

Items : 12

Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2022 Mar;163:44-54. doi: 10.1016/j.ejca.2021.12.023. Epub 2022 Jan 13.

2022
AOU Alessandria
ASL Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Dianzani I; Matullo G; Magnani C; Ferrante D; Moro L; Migliore E; Mirabelli D; Papotti M; Scagliotti GV; Giachino D; Boldorini R; Aspesi A; Pinton G; Clavenna MG; Casalone E; Allione A; Grosso F; Libener R; Muzio A; Baietto G; Parini S; Sculco M; La Vecchia M; Rena O;

SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma. in Journal of experimental & clinical cancer research : CR / J Exp Clin Cancer Res. 2022 Feb 23;41(1):75. doi: 10.1186/s13046-022-02284-7.

2022
AOU San Luigi di Orbassano

Salaroglio IC; Belisario DC; Bironzo P; Ananthanarayanan P; Ricci L; Digiovanni S; Fontana S; Napoli F; Sandri A; Facolmatà C; Libener R; Comunanza V; Grosso F; Gazzano E; Leo F; Taulli R; Bussolino F; Righi L; Papotti MG; Novello S; Scagliotti GV; Riganti C; Kopecka J;

Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition. in Virchows Archiv : an international journal of pathology / Virchows Arch. 2022 Aug;481(2):233-244. doi: 10.1007/s00428-022-03321-8. Epub 2022 Apr 24.

2022
AOU San Luigi di Orbassano

Napoli F; Rapa I; Izzo S; Rigutto A; Libener R; Riganti C; Bironzo P; Taulli R; Papotti M; Volante M; Scagliotti G; Righi L;

Correction to: Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition. in Virchows Archiv : an international journal of pathology / Virchows Arch. 2022 Aug;481(2):331. doi: 10.1007/s00428-022-03355-y.

2022
AOU San Luigi di Orbassano

Napoli F; Rapa I; Izzo S; Rigutto A; Libener R; Riganti C; Bironzo P; Taulli R; Papotti M; Volante M; Scagliotti G; Righi L;

Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma. in Cancers / Cancers (Basel). 2021 May 12;13(10):2332. doi: 10.3390/cancers13102332.

2021
AOU Alessandria
AOU San Luigi di Orbassano

Aviles P; Libener R; Leo F; Guerrera F; Sandri A; Comunanza V; Gigliotti C; Bussolino F; Di Nicolantonio F; Pittaro A; Papotti MG; Napoli F; Righi L; Morena D; Lingua MF; Picca F; Bironzo P; Anobile DP; Novello S; Taulli R; Scagliotti GV; Riganti C;

Wnt/IL-1?/IL-8 autocrine circuitries control chemoresistance in mesothelioma initiating cells by inducing ABCB5. in International journal of cancer / Int J Cancer. 2020 Jan 1;146(1):192-207. doi: 10.1002/ijc.32419. Epub 2019 Jun 4.

2020
AOU San Luigi di Orbassano

Milosevic V; Kopecka J; Salaroglio IC; Libener R; Napoli F; Izzo S; Orecchia S; Ananthanarayanan P; Bironzo P; Grosso F; Tabbò F; Comunanza V; Alexa-Stratulat T; Bussolino F; Righi L; Novello S; Scagliotti GV; Riganti C; Milosevic V; Kopecka J; Salaroglio IC; Libener R; Napoli F; Izzo S; Orecchia S; Ananthanarayanan P; Bironzo P; Grosso F; Tabbò F; et alii...

Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma. in Proceedings of the National Academy of Sciences of the United States of America / Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2226-2231. doi: 10.1073/pnas.1818865116. Epub 2019 Jan 1

2019
AOU San Luigi di Orbassano

Villanova T; Gesmundo I; Audrito V; Vitale N; Silvagno F; Musuraca C; Righi L; Libener R; Riganti C; Bironzo P; Deaglio S; Papotti M; Cai R; Sha W; Ghigo E; Schally AV; Granata R;

Loss of C/EBP-? LIP drives cisplatin resistance in malignant pleural mesothelioma. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2018 Jun;120:34-45. doi: 10.1016/j.lungcan.2018.03.022. Epub 2018 Mar 26.

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Rubinstein M; Novello S; Di Maio M; Napoli F; Pradotto M; Capelletto E; Ricci L; Ananthanarayanan P; Milosevic V; Grosso F; Libener R; Orecchia S; Salaroglio IC; Righi L; Kopecka J; Scagliotti GV; Riganti C;

Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural Mesothelioma. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2018 Jan;13(1):124-133. doi: 10.1016/j.jtho.2017.09.1968. Epub 2017 Oct 24.

2018
AOU San Luigi di Orbassano

Patil NS; Righi L; Koeppen H; Zou W; Izzo S; Grosso F; Libener R; Loiacono M; Monica V; Buttigliero C; Novello S; Hegde PS; Papotti M; Kowanetz M; Scagliotti GV; Patil NS; Righi L; Koeppen H; Zou W; Izzo S; Grosso F; Libener R; Loiacono M; Monica V; Buttigliero C; Novello S; Hegde PS; Papotti M; Kowanetz M; et alii...

Bromodomain inhibition exerts its therapeutic potential in malignant pleural mesothelioma by promoting immunogenic cell death and changing the tumor immune-environment. in Oncoimmunology / Oncoimmunology. 2017 Nov 27;7(3):e1398874. doi: 10.1080/2162402X.2017.1398874. eCollection 2018.

2018
AOU San Luigi di Orbassano

Riganti C; Lingua MF; Salaroglio IC; Falcomatà C; Righi L; Morena D; Picca F; Oddo D; Kopecka J; Pradotto M; Libener R; Orecchia S; Bironzo P; Comunanza V; Bussolino F; Novello S; Scagliotti GV; Di Nicolantonio F; Taulli R; Riganti C; Lingua MF; Salaroglio IC; Falcomatà C; Righi L; Morena D; Picca F; Oddo D; Kopecka J; Pradotto M; et alii...

Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma. in Cancer letters / Cancer Lett. 2017 Oct 1;405:38-45. doi: 10.1016/j.canlet.2017.06.028. Epub 2017 Jul 4.

2017
ASL Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Sculco M; Mancuso G; Guarrera S; Righi L; Grosso F; Libener R; Pavesi M; Mariani N; Casadio C; Boldorini R; Mirabelli D; Pasini B; Magnani C; Matullo G; Dianzani I; Aspesi A; Morleo G; Biasi A; Betti M; Casalone E; Ferrante D;

CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma. in Cancer letters / Cancer Lett. 2016 Aug 10;378(2):120-30. doi: 10.1016/j.canlet.2016.05.011. Epub 2016 May 12.

2016
AO Cuneo
ASL Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Magnani C; Dianzani I; Pasini B; Matullo G; Papotti M; Boldorini R; Righi L; Bracco C; Miccoli S; Mirabelli D; Pavesi M; Piccolini E; Colombo E; Dianzani C; Ascoli V; Casadio C; Maffè A; Turchetti D; Rosato S; Grosso F; Libener R; Farinelli P; Giorgione R; Gironi LC; Ogliara P; Ferrante D; Casalone E; Betti M; Aspesi A; et alii...